D
Revolution Medicines, Inc.
RVMD
$39.12
$0.090.23%
D
Sell
3/14/2023Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D+ on 3/14/2023 due to a decline in the total return index.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D+ on 3/14/2023 due to a decline in the total return index.
D
Sell
3/1/2023Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D+ from D on 3/1/2023 due to a major increase in the growth index, total return index and solvency index. Total revenue increased 356.79% from $3.36M to $15.33M, earnings per share increased from -$0.8658 to -$0.6338, and EBIT increased 19.37% from -$76.53M to -$61.71M.
Revolution Medicines, Inc. (RVMD) was upgraded to D+ from D on 3/1/2023 due to a major increase in the growth index, total return index and solvency index. Total revenue increased 356.79% from $3.36M to $15.33M, earnings per share increased from -$0.8658 to -$0.6338, and EBIT increased 19.37% from -$76.53M to -$61.71M.
D
Sell
2/23/2023Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, valuation index and volatility index.
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, valuation index and volatility index.
D
Sell
2/8/2023Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
11/30/2022Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 11/30/2022 due to an increase in the solvency index, growth index and volatility index. The quick ratio increased from 7.35 to 9.01, and operating cash flow increased 7.14% from -$55.72M to -$51.74M.
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 11/30/2022 due to an increase in the solvency index, growth index and volatility index. The quick ratio increased from 7.35 to 9.01, and operating cash flow increased 7.14% from -$55.72M to -$51.74M.
D
Sell
5/11/2022Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 5/11/2022 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 40.48% from -$39.27M to -$55.16M, total revenue declined 19.89% from $9.46M to $7.58M, and EBIT declined 9.52% from -$52.91M to -$57.95M.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 5/11/2022 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 40.48% from -$39.27M to -$55.16M, total revenue declined 19.89% from $9.46M to $7.58M, and EBIT declined 9.52% from -$52.91M to -$57.95M.
D
Sell
5/4/2022Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 5/4/2022 due to an increase in the volatility index and valuation index.
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 5/4/2022 due to an increase in the volatility index and valuation index.
D
Sell
4/18/2022Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index and valuation index.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 4/18/2022 due to a decline in the volatility index and valuation index.
D
Sell
3/22/2022Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 3/22/2022 due to an increase in the volatility index.
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 3/22/2022 due to an increase in the volatility index.
D
Sell
3/2/2022Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 3/2/2022 due to a decline in the growth index, volatility index and total return index. Operating cash flow declined 7.32% from -$36.59M to -$39.27M.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 3/2/2022 due to a decline in the growth index, volatility index and total return index. Operating cash flow declined 7.32% from -$36.59M to -$39.27M.
D
Sell
11/11/2021Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 11/11/2021 due to an increase in the total return index and volatility index.
Revolution Medicines, Inc. (RVMD) was upgraded to D from D- on 11/11/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, volatility index and growth index. EBIT declined 19.09% from -$37.4M to -$44.54M, earnings per share declined from -$0.5279 to -$0.6035, and total revenue declined 14.14% from $10.13M to $8.7M.
Revolution Medicines, Inc. (RVMD) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, volatility index and growth index. EBIT declined 19.09% from -$37.4M to -$44.54M, earnings per share declined from -$0.5279 to -$0.6035, and total revenue declined 14.14% from $10.13M to $8.7M.
D
Sell
6/15/2021Downgrade
Revolution Medicines, Inc. (RVMD) was downgraded to D from D+ on 6/15/2021 due to a decline in the total return index, volatility index and valuation index.
Revolution Medicines, Inc. (RVMD) was downgraded to D from D+ on 6/15/2021 due to a decline in the total return index, volatility index and valuation index.
D
Sell
5/11/2021Upgraded
Revolution Medicines, Inc. (RVMD) was upgraded to D+ from D on 5/11/2021 due to a large increase in the total return index, valuation index and volatility index.
Revolution Medicines, Inc. (RVMD) was upgraded to D+ from D on 5/11/2021 due to a large increase in the total return index, valuation index and volatility index.
D
Sell
5/15/2020None
Revolution Medicines, Inc. (RVMD) was downgraded to D from U on 05/15/2020.
Revolution Medicines, Inc. (RVMD) was downgraded to D from U on 05/15/2020.
NASDAQ
03/14/2025 4:00PM Eastern
Quotes delayed
